Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Mooij

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Biochimica Et Biophysica Acta|December 20, 2011
Pathophysiology of hypertriglyceridemiaH C Hassing, R P Surendran, H L Mooij, et al.
Diabetologia|September 25, 2010
Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitusL N Broekhuizen, B A Lemkes, H L Mooij, et al.
Atherosclerosis|June 14, 2008
Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbationM Nieuwdorp, M C Meuwese, H L Mooij, et al.
Journal of the American Heart Association|December 4, 2014
Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial functionH L Mooij, P Cabrales, S J Bernelot Moens, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta|December 20, 2011
Pathophysiology of hypertriglyceridemiaH C Hassing, R P Surendran, H L Mooij, et al.
Diabetologia|September 25, 2010
Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitusL N Broekhuizen, B A Lemkes, H L Mooij, et al.
Atherosclerosis|June 14, 2008
Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbationM Nieuwdorp, M C Meuwese, H L Mooij, et al.
Journal of the American Heart Association|December 4, 2014
Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial functionH L Mooij, P Cabrales, S J Bernelot Moens, et al.
Pageof 1